Patents by Inventor Bruno Filoche

Bruno Filoche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6392042
    Abstract: A pharmaceutical composition containing at least one stereoisomer of at least one compound selected from: Or a salt thereof with an organic or inorganic acid.
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: May 21, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Georges Bashiardes, Jean-Christophe Carry, Michel Evers, Bruno Filoche, Serge Mignani
  • Patent number: 6362185
    Abstract: The present invention relates to medicaments comprising at least one compound of formula: wherein either R1 represents a —CH(Ra)—CHOH—CHOH—CH2OH chain and R2 represents a —CH2—CHOH—CHOH—CH2OH chain, or R1 represents a —CHOH—CHF—CHOH—CH2OH chain and R2 represents a —CH2—CHF—CHOH—CH2OH chain, or R1 represents a —CHOH—CHOH—CHOH—Rb chain and R2 represents a —CH2—CHOH—CHOH—Rb chain, or R1 represents a —CH2—CHOH—CHOH—CH2OH chain and R2 represents a —CH2—CHOH—CHOH—CH2OH chain, or R1 and R2 are identical and each represent a —(CHOH)n—CH2OH chain in which n is equal to 1, 2, 3 or 4, Ra represents an alkoxy radical (1-6 C in a straight or branched chain) or a fluorine atom, and Rb represents a carboxyl, —CO—NH2 or —CH2—NH2 radical, or one of their stereoisomers or thei
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: March 26, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Georges Bashiardes, Jean-Christophe Carry, Michel Evers, Bruno Filoche, Serge Mignani
  • Patent number: 6355631
    Abstract: The present invention relates to pharmaceutical compositions containing, as an active ingredient, at least one compound of formula: in which R1 represents a radical —N(R4)R5, —N(R4)—CO—R5, —N(R4)—SO2R6 or one of its pharmaceutically acceptable salts, to the novel derivatives of formula (I), to their pharmaceutically acceptable salts and to their preparation.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: March 12, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Daniel Achard, Hervé Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Publication number: 20020019383
    Abstract: The present invention relates to pharmaceutical compositions containing, as active ingredient, a compound of formula: 1
    Type: Application
    Filed: March 2, 2001
    Publication date: February 14, 2002
    Inventors: Daniel Achard, Herve Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Publication number: 20010027193
    Abstract: Compounds of formula: 1
    Type: Application
    Filed: March 2, 2001
    Publication date: October 4, 2001
    Inventors: Daniel Achard, Herve Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Patent number: 6288066
    Abstract: Disclosed are polyhydroxybutylpyrazines of the general formula Including their isomers, racemates, enantioners and salts thereof, as well as processes for preparing these compounds and medicaments containing them.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: September 11, 2001
    Assignee: Aventis Pharma S.A.
    Inventors: Georges Bashiardes, Jean-Christophe Carry, Michel Evers, Bruno Filoche, Serge Mignani
  • Publication number: 20010018439
    Abstract: The invention concerns medicines containing as active principle at least a compound of formula (I): 1
    Type: Application
    Filed: January 11, 2001
    Publication date: August 30, 2001
    Inventors: Georges Bashiardes, Jean-Christophe Carry, Michel Evers, Bruno Filoche, Serge Mignani
  • Patent number: 5994299
    Abstract: Cyclosporin compounds of formula (I): ##STR1## wherein Alk and R are as defined herein, or a pharmaceutically acceptable salt thereof, which derivatives are useful in the treatment and/or prophylaxis of retrovirus infections.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: November 30, 1999
    Assignee: Rhone-Poulenc Rorer, S.A.
    Inventors: Jean-Claude Barriere, Georges Bashiardes, Jean-Christophe Carry, Michel Evers, Bruno Filoche, Serge Mignani
  • Patent number: 5977067
    Abstract: Cyclosporin derivatives of formula (I) in which R is H or a radical (Ia) or (Ib) as defined herein; R' is a radical (Ic) or (Id) as defined herein; and R"represents H or OH, with the proviso that R and R" are not simultaneously H, and pharmaceutically acceptable salts thereof, when they exist, are disclosed as useful for the treatment and/or prophylaxis of retrovirus infections.
    Type: Grant
    Filed: April 30, 1998
    Date of Patent: November 2, 1999
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Michel Evers, Serge Mignani, Jean-Christophe Carry, Bruno Filoche, Georges Bashiardes, Claude Bensoussan, Jean-Christophe Gueguen, Jean-Claude Barriere
  • Patent number: 5965527
    Abstract: A cyclosporin compound of the formula (I): ##STR1## wherein Alk and R are as defined herein, or a pharmaceutically acceptable salt thereof, which derivatives are is useful in the treatment and/or prophylaxis of retrovirus infections.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: October 12, 1999
    Assignee: Rhone-Poulenc Rorer, S.A.
    Inventors: Jean-Claude Barriere, Georges Bashiardes, Jean-Christophe Carry, Michel Evers, Bruno Filoche, Jean-Pierre Leconte, Serge Mignani
  • Patent number: 5948755
    Abstract: The cyclosporin compound of formula (I) is particularly useful in the treatment and/or prophylaxis of retrovirus infections.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: September 7, 1999
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Jean-Claude Barriere, Georges Bashiardes, Jean-Christophe Carry, Michel Evers, Bruno Filoche, Serge Mignani